Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04882384 · ClinicalTrials.gov registry record · NA
Pericapsular Nerve Group Block for Hip Fractures
A NA study, sponsored by Jacobi Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04882384 is a NA study that has completed, run by Jacobi Medical Center. The registered enrollment target is 10 participants.
The verdict
NCT04882384, a NA study, has completed, sponsored by Jacobi Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This will be a feasibility study to see if it feasible to perform the Pericapsular Nerve Group Block for hip fractures in the Emergency Department. In addition, we will look at the efficacy of the block in these 10 patients by measuring pain scores at pre-determine time points for 16 hours.
Interventions
- PROCEDURE Pericapsular Nerve Group Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2022-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04882384
The ClinicalTrials.gov registry entry for NCT04882384 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jacobi Medical Center, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pericapsular Nerve Group Block is the first listed.
NCT04882384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04882384 about?
NCT04882384 is a clinical study titled "Pericapsular Nerve Group Block for Hip Fractures". This will be a feasibility study to see if it feasible to perform the Pericapsular Nerve Group Block for hip fractures in the Emergency Department. In addition, we will look at the efficacy of the block in these 10 patients by measuring pain scores at pre-determine time points for 16 hours.
What is the current status of trial NCT04882384?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-07-01. Estimated completion is 2022-03-15.
What interventions are being tested in trial NCT04882384?
The interventions under investigation include: Pericapsular Nerve Group Block (PROCEDURE).
Who is sponsoring clinical trial NCT04882384?
This trial is sponsored by Jacobi Medical Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.